INS and metabolic dysfunction-associated steatohepatitis: Unlike HCC secondary to non-NASH diseases, NASH-related HCC pathogenesis is uniquely affected by a cascade of insulin resistance which causes oxidative stress, inflammation, and fibrosis-stimulating cytokines (4, 26).